Literature DB >> 30193533

Right ventricular involvement in transthyretin amyloidosis.

Sandra Arvidsson1, Michael Y Henein2, Gerhard Wikström3, Ole B Suhr2, Per Lindqvist1,4.   

Abstract

BACKGROUND: The extent of right ventricular (RV) involvement in transthyretin amyloidosis (ATTR) is unknown.
OBJECTIVES: This study sought to establish the degree of RV involvement in ATTR amyloidosis, and compare findings with RV involvement in hypertrophic cardiomyopathy (HCM).
METHODS: Forty-two patients with ATTR amyloidosis and echocardiographic evidence of cardiac amyloidosis (cardiac ATTR), 19 ATTR patients with normal left ventricular (LV) wall thickness (non-cardiac ATTR), 25 patients with diagnosed HCM and 30 healthy controls were included in this study. Echocardiographic measurements for conventional parameters, as well as RV global and segmental strain, were recorded.
RESULTS: When comparing RV structure and function between cardiac ATTR amyloidosis and HCM patients, only segmental strain differed between the two groups. In cardiac ATTR amyloidosis, we found an RV apex-to-base strain gradient with highest deformation in the apex. This pattern was reversed in patients with HCM.
CONCLUSIONS: RV involvement is common in cardiac ATTR patients. The present study also detected an RV apical sparing pattern in patients with ATTR cardiomyopathy, similar to what has previously been described for the left ventricle in these patients. This pattern was not seen in HCM patients. Further studies are needed to assess the clinical importance of these findings.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; amyloid cardiomyopathy; apical sparing; right ventricle; strain

Mesh:

Year:  2018        PMID: 30193533     DOI: 10.1080/13506129.2018.1493989

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  9 in total

Review 1.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 2.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

Review 3.  Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.

Authors:  Vasiliki Bistola; John Parissis; Emmanouil Foukarakis; Pipitsa N Valsamaki; Aris Anastasakis; Georgios Koutsis; Georgios Efthimiadis; Efstathios Kastritis
Journal:  Heart Fail Rev       Date:  2021-01-15       Impact factor: 4.214

Review 4.  The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update.

Authors:  Radu Sascău; Larisa Anghel; Alexandra Clement; Mădălina Bostan; Rodica Radu; Cristian Stătescu
Journal:  Diagnostics (Basel)       Date:  2021-02-07

Review 5.  99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.

Authors:  Nobuhiro Tahara; Olivier Lairez; Jin Endo; Atsushi Okada; Mitsuharu Ueda; Tomonori Ishii; Yoshinobu Kitano; Hahn-Ey Lee; Eleonora Russo; Toru Kubo
Journal:  ESC Heart Fail       Date:  2021-11-29

6.  Distinguishing Cardiac Amyloidosis and Hypertrophic Cardiomyopathy by Thickness and Myocardial Deformation of the Right Ventricle.

Authors:  Hui Liu; Peng Bai; Hua-Yan Xu; Zhen-Lin Li; Chun-Chao Xia; Xiao-Yue Zhou; Liang-Geng Gong; Ying-Kun Guo
Journal:  Cardiol Res Pract       Date:  2022-02-01       Impact factor: 1.866

7.  RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis.

Authors:  Elsa Arnberg; Per Eldhagen; Viktor Löfbacka; Ashwin Venkateshvaran; Björn Pilebro; Per Lindqvist
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

8.  Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.

Authors:  M Y Henein; B Pilebro; Per Lindqvist
Journal:  Heart Vessels       Date:  2022-03-11       Impact factor: 1.814

9.  Biventricular Strain Imaging with Cardiac MRI in Genotyped and Histology Validated Amyloid Cardiomyopathy.

Authors:  Abhinay Reddy; Vasvi Singh; Badri Karthikeyan; Leyi Jiang; Silva Kristo; Sharma Kattel; Ram Amuthan; Saraswati Pokharel; Umesh C Sharma
Journal:  Cardiogenetics       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.